| __timestamp | Protagonist Therapeutics, Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1860000 | 1244910 |
| Thursday, January 1, 2015 | 2963000 | 5029636 |
| Friday, January 1, 2016 | 6961000 | 4846776 |
| Sunday, January 1, 2017 | 11779000 | 5329003 |
| Monday, January 1, 2018 | 13697000 | 7121000 |
| Tuesday, January 1, 2019 | 15749000 | 9128000 |
| Wednesday, January 1, 2020 | 18638000 | 10731000 |
| Friday, January 1, 2021 | 27196000 | 10701000 |
| Saturday, January 1, 2022 | 31739000 | 16121000 |
| Sunday, January 1, 2023 | 33491000 | 37021000 |
Unlocking the unknown
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining financial health. Viking Therapeutics, Inc. and Protagonist Therapeutics, Inc. have been navigating these waters since 2014. Over the years, Protagonist Therapeutics has seen a steady increase in SG&A expenses, peaking at approximately 33 million in 2023, a nearly 18-fold increase from 2014. Meanwhile, Viking Therapeutics experienced a more volatile trajectory, with a significant spike in 2023, reaching around 37 million, marking a 29-fold increase from their 2014 figures. This data suggests that while both companies have expanded their operations, Viking's recent surge indicates a potential shift in strategy or market conditions. Investors and industry analysts should keep a close eye on these trends as they reflect broader strategic decisions and market dynamics.
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or Viking Therapeutics, Inc.
AstraZeneca PLC vs Viking Therapeutics, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Amgen Inc. vs Viking Therapeutics, Inc.
Who Optimizes SG&A Costs Better? GSK plc or Protagonist Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing argenx SE and Protagonist Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Genmab A/S or Viking Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Neurocrine Biosciences, Inc. and Viking Therapeutics, Inc.
Comparing SG&A Expenses: Catalent, Inc. vs Viking Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs Protagonist Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Opthea Limited and Protagonist Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Verona Pharma plc and Protagonist Therapeutics, Inc.
Viking Therapeutics, Inc. and Perrigo Company plc: SG&A Spending Patterns Compared